Spyre Therapeutics is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (âIBDâ) and rheumatic diseases.
Director, Analytical Sciences is responsible for overseeing biologics analytical development and testing activities across Spyreâs clinical and late stage mAb programs. Provides strategic and technical leadership for analytical development and quality control activities across the biologics portfolio, including method development, validation, transfer, and lifecycle management, with primary execution through global CDMO partners.
Spyre Therapeutics is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (âIBDâ) and rheumatic diseases.